Display Settings:

Format

Send to:

Choose Destination

    AIDS. 2008 May 11;22(8):989-90.

    Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?

    Scott C, Grover D, Nelson M.

    St. Stephens Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

    Erratum in:

    • AIDS. 2008 Sep 12;22(14):i.

    Etravirine is a next generation nonnucleoside reverse transcriptase inhibitor with activity against nonnucleoside reverse transcriptase inhibitor resistant HIV-1 virus. Susceptibility and virological response to etravirine is dependent on the type and number of nonnucleoside reverse transcriptase inhibitor resistance-associated mutations. We examined the predicted susceptibility of etravirine in patients experiencing virological failure secondary to nonnucleoside reverse transcriptase inhibitor resistance in our patient cohort.

    PMID: 18453859 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Etravirine (Intelence®)

      Etravirine is used with other medications to treat human immunodeficiency virus (HIV) infection in people with or without acquired immunodeficiency syndrome (AIDS) whose HIV infection has not been controlled with other m...